Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

Add to Watch List

Set Alert

58.36 Data as of May 17	+0.04 / +0.07% Today’s Change	40.38 Today\|\|\|52-Week Range 60.79	+9.60% Year-to-Date

58.36

Data as of May 17

+0.04 / +0.07%

Today’s Change

40.38

Today|||52-Week Range

60.79

+9.60%

Year-to-Date

SECTOR

Health Technology

INDUSTRY

Pharmaceuticals: Other

MARKET CAP

$3.4B

Company Description

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products. The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded on January 18, 2012 and is headquartered in Dublin, Ireland.

Contact Information

Jazz Pharmaceuticals Plc

Connaught House

Dublin Dublin 4

P:(531) 634-7800

Investor Relations:
(531) 638-1032

www.jazzpharma.com

Employees

Shareholders

Mutual fund holders	47.24%
Other institutional	36.50%
Individual stakeholders	24.13%

Top Executives

Bruce C. Cozadd, MBA	Chairman & Chief Executive Officer
Fintan Keegan	Secretary & Executive VP-Technical Operations
Kathryn E. Falberg, MBA, CPA	Chief Financial Officer & Executive Vice President
Mark G. Eller, PhD	Senior VP-Research & Clinical Development
Jeffrey K. Tobias, MD	Chief Medical Officer, EVP-Research & Development

To view my watchlist

Not a member yet?

jobs by

Search for jobs

Search All Jobs from Across the Web

About CNNMoney
Content
Magazines
Site Tools
Stay Connected
- My Account
- Mobile Site & Apps
- Facebook
- Twitter
- LinkedIn
- YouTube
- RSS Feeds
- Newsletters
- Tumblr
- Google+

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones Indexes^SM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones Indexes^SM © 2013 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved. Most stock quote data provided by BATS.